Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Borstol** is an over-the-counter expectorant cough syrup available in peppermint and orange flavors, primarily used for symptomatic relief of general and chronic troublesome coughs, phlegmy (wet) coughs, and hoarseness associated with colds, influenza, and bronchitis. It works by loosening, thinning, and helping to expel phlegm from the airways, making it easier to clear mucus produced during respiratory infections. Marketed in 50 ml and 100 ml bottles, it targets chesty coughs caused by infections like the common cold, flu, or chest infections, and provides relief for scratchy throat symptoms leading to raspy or altered vocal sounds.[1][2][3][4][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Borstol.